Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Technology: Markers

Approach Summary Licensing status Publication and contact information
Markers
Ribosomal protein S6 kinase (RSK) phosphorylation to predict response to BRAF, MEK or

Read the full 284 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE